“melanoma” Archives

in
Entry Author Date Location
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News 04/28/11 San Diego
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors 04/27/11 San Diego
San Diego VC Activity Falls 55 Percent, Ford Adopts Focus as EV “Tech Platform,” Verve Raises $3.5M, & More San Diego BizTech News 04/18/11 San Diego
West Wireless Health Institute Awards $10K Incentive Prize 04/13/11 San Diego
Bigger Isn’t Better: It’s Time for Big Pharma to Break Up Into Little Pharma 03/28/11 National
Plexxikon, Creator of Hot Melanoma Drug, Bought by Daiichi Sankyo for $805M Upfront 02/28/11 San Francisco
Amgen’s R&D Chief, Roger Perlmutter, on Why BioVex’s Cancer-Fighting Virus Is Worth $1B 01/26/11 Boston
Plexxikon Cancer Drug Extends Lives, Med Devices Lose Swagger, Amgen Sells Fremont Facility, & More Bay Area Life Sciences News 01/21/11 San Francisco
Plexxikon, Roche Drug Extends Lives in Patients With Deadly Skin Cancer 01/19/11 San Francisco
E-Commerce Pioneer Sets Up Cancer Commons, Affymax Hires New Boss, Plexxikon Opts In, & More Bay Area Life Sciences News 01/07/11 San Francisco
Plexxikon Opts to Co-Promote with Genentech 01/06/11 San Francisco
Internet Commerce Pioneer Seeks to Crack Secretive Culture With Cancer Commons 01/04/11 San Francisco
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
Bristol-Myers Almost Ready to Seal the Deal, Complete Takeover of ZymoGenetics 10/08/10 Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News 09/30/10 Seattle
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline 09/29/10 Seattle
iPierian Entices Corporate VCs, Plexxikon’s One-Two Punch, Jennerex’s Road Less Traveled, & More Bay Area Life Sciences News 09/10/10 San Francisco
Jennerex, Charging Ahead With Tumor-Killing Virus, Follows Biotech Road Less Traveled 09/09/10 San Francisco
Plexxikon Shows How New Drug Hits Molecular Target for Deadly Skin Cancer 09/07/10 San Francisco
A Bidding War for 3Par, a Trademark War over Mafia Wars, a Barrage of New Y Combinator Startups, & More Bay Area BizTech and Life Sciences News 08/30/10 San Francisco
Promising Skin Cancer Drug Could Be First Big Win for Plexxikon’s Structure-Based Drug Discovery Approach 08/26/10 San Francisco
After the Meltdown: Synta Pharma CEO Trumpets New Top Cancer Drug 07/12/10 Boston
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
Bezos Family Pledges $10M to the “Hutch” for Next-Generation Cancer Therapies 11/23/09 Seattle
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus 11/10/09 Boston
Zymo Melanoma Drug Shrinks Tumors 05/13/09 Seattle
Synta Melanoma Drug Fails Disastrously in Clinical Trial, As Patients Show Higher Death Rate 02/26/09 Boston
Synta Melanoma Data Coming in May 02/02/09 Boston
Synta, Developer of New Class of Cancer Drugs, Eagerly Awaits Results From Key Trial 01/27/09 Boston
Synta Gets $25M From Glaxo For Cancer Drug Milestone 10/14/08 Boston
Page 2 of 3 « previous page · next page »